| Overall (N = 2679) | Tertile of SBP-wSD | |||
---|---|---|---|---|---|
T1 (N = 895) | T2 (N = 894) | T3 (N = 890) | P-trend value | ||
Demographic | |||||
 Age, y | 47.53 ± 14.06 | 42.55 ± 12.77 | 47.26 ± 13.97 * | 52.81 ± 13.52*‡ | < 0.001 |
 Male, N (%) | 1501(56.0) | 492(55.0) | 515(57.6) | 494(55.5) | 0.495 |
 BMI, kg/m2 | 24.18 ± 4.20 | 23.49 ± 4.25 | 24.22 ± 4.16 * | 24.82 ± 4.08*‡ | < 0.001 |
 Current smoker, N (%) | 505(18.9) | 132(14.7) | 182(20.4) * | 191(21.5) * | 0.001 |
 Alcohol intake, N (%) | 417(15.6) | 136(15.2) | 147(16.4) | 134(15.1) | 0.673 |
 Diabetes mellitus, N (%) | 592(22.1) | 95(10.6) | 176(19.7) * | 321(36.1) *‡ | < 0.001 |
 CVD history, N (%) | 384(14.3) | 81(9.1) | 114(12.8) * | 189(21.2) *‡ | < 0.001 |
 Hypertension history, N (%) | 1360(50.8) | 303(33.9) | 461(51.6) * | 596(67.0)*‡ | < 0.001 |
 Statins, N (%) | 711(26.5) | 198(22.1) | 223(24.9) | 290(32.6)*‡ | < 0.001 |
Etiology of CKD | |||||
 Glomerulonephritis, N (%) | 1621(60.5) | 618(69.1) | 558(62.4) * | 445(50.0) *‡ | < 0.001 |
 Diabetic kidney disease, N (%) | 296(11.0) | 33(3.7) | 81(9.1) * | 182(20.4) *‡ | < 0.001 |
 Hypertensive nephropathy, N (%) | 168(6.3) | 38(4.2) | 52(5.8) | 78(8.8) *‡ | < 0.001 |
 Lupus nephropathy, N (%) | 84(3.1) | 27(3.0) | 24(2.7) | 33(3.7) | 0.449 |
 Others, N (%) | 510(19.0) | 179(20.0) | 179(20.0) | 152(17.1) | 0.190 |
Laboratory | |||||
 FBG, mmol/L | 4.80(4.32,5.50) | 4.64(4.24,5.14) | 4.80(4.34,5.45) | 5.00(4.45,6.00)*‡ | < 0.001 |
 Hemoglobin, g/L | 124.66 ± 25.92 | 128.55 ± 23.58 | 126.39 ± 26.57 | 119.00 ± 26.55*‡ | < 0.001 |
 Serum albumin, g/L | 38.63(33.40,42.00) | 39.20(34.20,42.50) | 39.00(33.75,42.35) | 37.70(32.58,41.40) | 0.007 |
 Uric acid, mmol/L | 425.64 ± 120.82 | 409.18 ± 119.08 | 429.48 ± 122.38 * | 438.35 ± 119.26* | < 0.001 |
 Cholesterol, mmol/L | 4.74(3.93,5.89) | 4.67(3.90,5.69) | 4.78(3.94,5.87) | 4.80(3.93,6.09) | 0.935 |
 HDL-C, mmol/L | 1.10(0.90,1.37) | 1.13(0.94,1.43) | 1.10(0.89,1.38) | 1.07(0.88,1.32)* | 0.008 |
 LDL-C, mmol/L | 2.76(2.11,3.57) | 2.73(2.14,3.48) | 2.77(2.10,3.52) | 2.77(2.11,3.77) | 0.954 |
 Serum calcium, mmol/L | 2.15(2.02,2.25) | 2.16(2.03,2.25) | 2.15(2.02,2.25) | 2.13(2.02,2.25) | 0.643 |
 Serum phosphate, mmol/L | 1.09(0.94,1.28) | 1.06(0.91,1.25) | 1.09(0.94,1.28) | 1.10 (0.95,1.33) | < 0.001 |
 iPTH, pmol/L | 5.11(3.35,9.30) | 4.66(3.20,7.27) | 4.88(3.21,9.44) * | 6.02(3.72,11.75)*‡ | < 0.001 |
 Blood urea nitrogen, mmol/L | 6.20(4.58,10.00) | 5.50(4.20,8.10) | 6.10(4.60,9.90) * | 7.40(5.10,12.40)*‡ | < 0.001 |
 Serum creatinine, µmol/L | 100.00(72.00,175.00) | 89.00(67.00,137.00) | 100.25 (72.00,176.25)* | 116.00(80.75,226.00)*‡ | < 0.001 |
 eGFR, ml/min/1.73 m2 | 69.00(35.00,101.00) | 85.00(51.00,108.00) | 70.00 (34.00,102.00)* | 55.00(24.00,88.00)*‡ | < 0.001 |
 UACR, mg/g | 475.88(60.19,1744.94) | 308.91(34.74,1410.84) | 407.53(58.60,1528.00) | 756.31(93.23,2456.83)*‡ | < 0.001 |
Blood pressure indices | |||||
 Clinic-SBP, mmHg | 135.43 ± 23.87 | 124.91 ± 19.21 | 135.07 ± 22.57* | 146.38 ± 24.54*‡ | < 0.001 |
 Clinic-DBP, mmHg | 85.62 ± 14.46 | 82.24 ± 12.71 | 86.31 ± 13.98* | 88.33 ± 15.88*‡ | < 0.001 |
 24 h-mean SBP, mmHg | 124.10 ± 16.21 | 115.59 ± 12.27 | 122.38 ± 14.03* | 134.37 ± 16.15*‡ | < 0.001 |
 24 h-mean DBP, mmHg | 81.09 ± 11.72 | 77.47 ± 10.35 | 80.66 ± 11.21* | 85.17 ± 12.23*‡ | < 0.001 |
 Hypertension by clinic-SBP, N (%) | 1052(39.3) | 176(19.7) | 343(38.4)* | 533(59.9)*‡ | < 0.001 |
 Hypertension by clinic-DBP, N (%) | 950(35.5) | 230(25.7) | 331(37.0)* | 389(43.7)*‡ | < 0.001 |
 24 h-SBP SD, mmHg | 12.41 ± 3.70 | 9.08 ± 1.39 | 11.81 ± 1.27* | 16.36 ± 3.25*‡ | < 0.001 |
 24 h-DBP SD, mmHg | 10.08 ± 3.26 | 8.41 ± 1.64 | 9.91 ± 1.79* | 11.94 ± 4.46*‡ | < 0.001 |
 Daytime-SBP SD, mmHg | 12.20 ± 3.87 | 8.71 ± 1.34 | 11.56 ± 1.28* | 16.35 ± 3.42*‡ | < 0.001 |
 Daytime-DBP SD, mmHg | 9.82 ± 3.00 | 8.10 ± 1.70 | 9.73 ± 3.22* | 11.65 ± 2.72*‡ | < 0.001 |
 Nighttime-SBP SD, mmHg | 9.41 ± 3.54 | 7.14 ± 2.13 | 9.15 ± 2.34* | 11.94 ± 4.00*‡ | < 0.001 |
 Nighttime-DBP SD, mmHg | 7.90 ± 2.83 | 6.53 ± 2.16 | 7.89 ± 2.37* | 9.29 ± 3.14*‡ | < 0.001 |
 SBP wSD, mmHg | 11.41 ± 3.32 | 8.28 ± 1.02 | 10.88 ± 0.74* | 15.10 ± 2.78*‡ | < 0.001 |
 DBP wSD, mmHg | 9.28 ± 2.46 | 7.67 ± 1.44 | 9.19 ± 2.33* | 10.99 ± 2.26*‡ | < 0.001 |
 Dippers, N (%) | 466(17.4) | 118(13.2) | 176(19.7)* | 172(19.3)* | < 0.001 |
 Non-dippers, N (%) | 1562(58.3) | 611(68.3) | 519(58.1)* | 432(48.5)*‡ | < 0.001 |
 Risers, N (%) | 645(24.1) | 169(18.9) | 199(22.3) | 277(31.1)*‡ | < 0.001 |
 Extreme dippers, N (%) | 17(0.6) | 1(0.1) | 4(0.4) | 12(1.3)* | 0.003 |
Antihypertensive treatment | |||||
 Antihypertension drugs, N (%) | 1108(41.4) | 252(28.2) | 365(40.8) * | 491(55.2) *‡ | < 0.001 |
 ACEI, N (%) | 142(5.3) | 51(5.7) | 48(5.4) | 43(4.8) | 0.712 |
 ARB, N (%) | 753(28.1) | 244(27.3) | 264(29.5) | 245(27.5) | 0.507 |
 β-blockers, N (%) | 477(17.8) | 105(11.7) | 160(17.9)* | 212(23.8)*‡ | < 0.001 |
 Calcium channel blockers, N (%) | 1153(43.0) | 244(27.3) | 390(43.6)* | 519(58.3)*‡ | < 0.001 |
 Others, N (%) | 193(7.2) | 29(3.2) | 52(5.8)* | 112(12.6)*‡ | < 0.001 |